APA

van Pelt G. W., Krol J. A., Lips I. M., Peters F. P., van Klaveren D., Boonstra J. J., de Steur W. O., Tollenaar R. A. E. M., Farina Sarasqueta A., Mesker W. E. & Slingerland M. (2020). The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer. : Clinical and translational radiation oncology.

Chicago

van Pelt G W, Krol J A, Lips I M, Peters F P, van Klaveren D, Boonstra J J, de Steur W O, Tollenaar R A E M, Farina Sarasqueta A, Mesker W E and Slingerland M. 2020. The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer. : Clinical and translational radiation oncology.

Harvard

van Pelt G. W., Krol J. A., Lips I. M., Peters F. P., van Klaveren D., Boonstra J. J., de Steur W. O., Tollenaar R. A. E. M., Farina Sarasqueta A., Mesker W. E. and Slingerland M. (2020). The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer. : Clinical and translational radiation oncology.

MLA

van Pelt G W, Krol J A, Lips I M, Peters F P, van Klaveren D, Boonstra J J, de Steur W O, Tollenaar R A E M, Farina Sarasqueta A, Mesker W E and Slingerland M. The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer. : Clinical and translational radiation oncology. 2020.